207_Combined course Presentations
Background
Cisplatin/Etoposide (CE) and Carboplatin/Paclitaxel (CP) are two of the most commonly utilized regimens for the treatment of stage III non-small cell lung cancer (NSCLC)
Made with FlippingBook
Background
Cisplatin/Etoposide (CE) and Carboplatin/Paclitaxel (CP) are two of the most commonly utilized regimens for the treatment of stage III non-small cell lung cancer (NSCLC)
Made with FlippingBook